Efficacy and safety of rasagiline in Chinese patients with early Parkinson ’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

ConclusionsRasagiline is effective, safe, and well tolerated as monotherapy for the treatment of Chinese PD patients.Trial registrationClinicaltrials.gov:NCT01556165. Registered 13 Mar 2012.
Source: Translational Neurodegeneration - Category: Neurology Source Type: research